1.52 0.07 (4.83%) | 02-14 16:00 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 1.96 | 1-year : | 2.29 |
Resists | First : | 1.67 | Second : | 1.96 |
Pivot price | 1.55 ![]() |
|||
Supports | First : | 1.38 | Second : | 1.21 |
MAs | MA(5) : | 1.47 ![]() |
MA(20) : | 1.54 ![]() |
MA(100) : | 2.11 ![]() |
MA(250) : | 2.93 ![]() |
|
MACD | MACD : | -0.1 ![]() |
Signal : | -0.1 ![]() |
%K %D | K(14,3) : | 24.1 ![]() |
D(3) : | 25.5 ![]() |
RSI | RSI(14): 46.3 ![]() |
|||
52-week | High : | 11.46 | Low : | 1.16 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ COCH ] has closed above bottom band by 37.5%. Bollinger Bands are 54% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 1.62 - 1.63 | 1.63 - 1.63 |
Low: | 1.39 - 1.4 | 1.4 - 1.41 |
Close: | 1.51 - 1.52 | 1.52 - 1.53 |
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.
Fri, 14 Feb 2025
Patent Powerhouse: Envoy Medical Locks Down 6 Strategic Patents Across US, Japan & Hong Kong - StockTitan
Fri, 14 Feb 2025
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio - Newsfile
Fri, 01 Nov 2024
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device - StockTitan
Tue, 01 Oct 2024
Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market - StockTitan
Thu, 12 Sep 2024
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
Fri, 24 May 2024
Will Envoy Medical Make The Right Noises About Acclaim CI? - RTTNews
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 0 (M) |
Shares Float | 21 (M) |
Held by Insiders | 7.15e+006 (%) |
Held by Institutions | 64.4 (%) |
Shares Short | 58 (K) |
Shares Short P.Month | 0 (K) |
EPS | -1.973e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -7 % |
Return on Assets (ttm) | 147 % |
Return on Equity (ttm) | -266.4 % |
Qtrly Rev. Growth | 302000 % |
Gross Profit (p.s.) | 3.34 |
Sales Per Share | 0 |
EBITDA (p.s.) | -232203 |
Qtrly Earnings Growth | -1.3 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -21 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | -39.86 |
Dividend | 0 |
Forward Dividend | 46880 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |